Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer

Showing 15 posts of 150 posts found.

Ben Venue image

1,100 jobs to go as Ben Venue confirms closure of Bedford unit

October 7, 2013
Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, FDA

Boehringer Ingelheim is calling time on its troubled facility in Ohio operated by Ben Venue Laboratories and says it will …

News
boehringer image

Boehringer cancer drug impresses

October 1, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC, nintedanib

Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …

News

Boehringer cuts ribbon on €70m addition to Shanghai plant

September 27, 2013
Manufacturing and Production, Sales and Marketing Boehringer, China, Shanghai

Boehringer Ingelheim has officially opened the €70 million expansion of its facility in Zhangjiang, China, that is designed to triple …

News

Boehringer and Ventana link up

September 24, 2013
Research and Development, Sales and Marketing Boehringer, Ventana, oncology

Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …

News

Boehringer to shut down Petersburg chemicals facility

August 16, 2013
Manufacturing and Production, Sales and Marketing Boehringer, Petersburg

Boehringer Ingelheim has conceded defeat in its search for a buyer for its chemicals facility in Petersburg, US, and is …

News

Boehringer nears European approval for first cancer drug

July 29, 2013
Sales and Marketing Boehringer, Cancer, FDA, afatinib

Boehringer’s first cancer drug is just months away from being approved in Europe after a committee for the EMA gave …

News

Boehringer and partners launch digital diabetes study

July 19, 2013
Medical Communications Boehringer, Syrum, Twitter, diabetes, digital, type 2

Boehringer Ingelheim has partnered with Healthrageous and United BioSource to establish a new diabetes study to help patients manage their …

News
boehringer_german_building_at_night_5

FDA approves Boehringer’s lung cancer drug

July 12, 2013
Medical Communications, Sales and Marketing Boehringer, FDA, Roche, Tarceva, afatinib, lung cancer

Boehringer Ingelheim’s late-stage lung cancer drug Gilotrif has received an accelerated FDA approval for patients with a certain genetic mutation. …

News
Xarelto image

FDA has Xarelto concerns

July 2, 2013
Sales and Marketing Bayer, Boehringer, FDA, Pradaxa, Xarelto

The FDA is unsure about an application to further extend the licence for Janssen and Bayer HealthCare’s blood thinner Xarelto …

News
Boehringer image

NSCLC lift for Boehringer

June 4, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC

Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …

News
Wireless bottle image

Wireless pill bottle wins Boehringer challenge

May 29, 2013
Medical Communications Boehringer, brett wells, wireless

Developers of a pill bottle that wirelessly measures medication and sends patient reminders have emerged as prize-winners in a Healthcare …

News

Boehringer held up by FDA for production violations

May 24, 2013
Manufacturing and Production API, Boehringer, FDA

Boehringer Ingelheim has pledged to resolve manufacturing compliance issues at a facility in Germany uncovered by the US Food and …

News
wefwefwefw

Board changes at Boehringer Ingelheim

May 22, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, baiker

Boehringer’s Professor Wolfram Carius is stepping down from the Board to be replaced by Dr Wolfgang Baiker. Carius who is …

Appointment
Boehringer image

Boehringer and OBT in cancer tie-up

May 2, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …

News

Boehringer’s online PMCPA breach

April 25, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA

Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023